Trial Profile
A retrospective study evaluating efficacy and safety of Infliximab in Chinese patients with Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 13 Aug 2016 New trial record